 - Patients with smoldering myeloma are eligible if there is evidence of progressive disease requiring therapy 25 increase in M protein levels or Bence Jones excretion; Hgb 10.5 gdl; frequent infections; hypercalcemia; rise in serum creatinine above normal on two separate occasion 